NUZ ASX · Health Care

Neurizon Therapeutics Ltd

Announcements, last 12 months: 105
Price sensitive, last 12 months: 30
Followed on InvestorPA: Low (Outside the 20% most-followed companies on InvestorPA)

Latest announcements

Released	Headline	Actions
23 Oct 2026, 9:09 AM	Change of AGM Date
13 Oct 2026, 4:37 PM	Notification of cessation of securities - NUZ
7 Oct 2026, 10:04 AM	Updated Investor Presentation and Webinar Reminder
6 Oct 2026, 9:57 AM	FDA Type C Feedback, HEALEY trial potentially registrational Price sensitive	AI summary
1 Oct 2026, 9:30 AM	Dr Chris Bremer commences as Neurizon CEO
17 Sep 2026, 1:59 PM	Change of Director's Interest Notice
15 Sep 2026, 6:17 PM	Notification of cessation of securities - NUZ
10 Sep 2026, 9:53 AM	Neurizon Announces Partial Redemption of Convertible Notes Price sensitive	AI summary
10 Sep 2026, 9:18 AM	Application for quotation of securities - NUZ
9 Sep 2026, 9:55 AM	NIH funds Expanded Access Program for NUZ-001 in ALS Price sensitive	AI summary

Sign in to see all NUZ announcements.

Guidance history

6 Oct 2026	Topline results for Regimen I expected in late Q2 CY2027
10 Sep 2026	Neurizon confirms full funding through to the topline readout of the HEALEY ALS Platform Trial.
7 Sep 2026	Topline results for NUZ-001 expected in late Q2 2027

Sign in to see the full guidance history.

Most followed in Health Care

PME Pro Medicus Ltd
AHC Austco Healthcare Ltd
CSL CSL Ltd
RMD Resmed Inc
TLX TELIX Pharmaceuticals Ltd
CGS Cogstate Ltd
ALC Alcidion Group Ltd
CSX Cleanspace Holdings Ltd

Follow NUZ to get its announcements emailed to you, with AI summaries, the full announcement and guidance history, and its most significant announcements.